AMCP

Today in managed care: The AP reports the CDC on Wednesday updated its “Vaccine Safety” webpage “to contradict the longtime scientific conclusion that vaccines do not cause autism, spurring outrage among a number of public health and autism experts.” apnews.com/article/cdc-au…

Happy Patient Experience Data Friday! Here is another Myth vs Fact on Patient Voice in Health Care Decision-Making. Access the report here: hubs.li/Q041yVbR0 #ManagedCare #PatientVoice #PatientExperienceData #Formulary #Payers

We'll be at #AMCP2026 in April & can't wait to connect with fellow attendees! Our Clinical Pharmacy Services team helps managed care orgs achieve high-quality patient outcomes while keeping pharmacy benefit programs cost-effective. @AMCPorg Learn more: brnw.ch/21x0Qsu

📅 #SaveTheDate: Attending the @amcporg 2026 Annual Meeting in Nashville, TN from April 13-16, our #ADVIExperts will be meeting with clients and colleagues throughout the event. Get in touch with our #ADVIHealth team at #AMCP2026: advi.com/events/advi-he…

AMCP has opened the public comment period for the Format for Formulary Submissions, Version 6.0. Your input will help shape the Format v6.0. Comments are being accepted through April 22, 2026. Review the proposed revisions and submit your comments: hubs.li/Q047z_MP0

Today in managed care: Modern Healthcare reports, “States shut down more troubled health insurance companies in 2025 than during the prior year, but the total remained below historical trends.” modernhealthcare.com/insurance/mh-h…

Today in managed care: HealthDay reports, “Insurance requirements could keep people from getting life-saving heart medications in a timely fashion, a new study says.” healthday.com/health-news/ca…

Today in managed care: The New York Times reports a federal judge in Massachusetts on Monday blocked the Administration “from implementing a series of decisions on vaccines made over the last year by Health Secretary Robert F. Kennedy Jr.” nytimes.com/2026/03/16/hea…

The House of Representatives reintroduced the bipartisan Medicaid VBPs for Patients (MVP) Act, which would modernize Medicaid’s framework for value-based purchasing arrangements. Take action and call on your Members of Congress to support this legislation: hubs.li/Q046_94w0

Today in managed care: The AP reported as the US flu season winds down, health officials “say the flu vaccine didn’t work very well, with one of its worst effectiveness rates in more than a decade.” apnews.com/article/flu-se…

AMCP Foundation & JMCP invite submissions on innovative approaches to reducing health disparities in managed care pharmacy. Up to two papers will receive $10,000 and be featured at the 2026 AMCP Foundation Symposium. Deadline: July 1, 2026. jmcp.org/authors-review…

Jessica spent years searching for answers before finally learning she was living with EOE. Her story highlights why timely diagnosis and clear pathways to specialty medications are essential for patients. Sponsored by Takeda #AMCP #WeAreMCPs amcp.org/patient-storie…

Happy Patient Experience Data Friday! Here is another Myth vs Fact on Patient Voice in Health Care Decision-Making. Access the report here: hubs.li/Q041yQ-T0 #ManagedCare #PatientVoice #PatientExperienceData #Formulary #Payers

Today in managed care: The New York Times reports that a survey released Thursday by the West Health-Gallup Center on Healthcare in America reveals that one-third of Americans, about 82 million people, are making sacrifices due to rising healthcare costs. nytimes.com/2026/03/12/hea…

Today in managed care: The Washington Post reports the Advisory Committee on Immunization Practices (ACIP) “has abandoned an attack on the COVID-19 mRNA vaccines.” washingtonpost.com/health/2026/03…

Our full statement: amcp.org/press-releases…

Take Action and call on your Members of Congress to support this legislation. votervoice.net/iframes/AMCP/C…

AMCP applauds @RepGuthrie, @RepAuchincloss, @RepMMM, @RepJohnJoyce, @RepScottPeters, and @RepDonDavis for reintroducing the #MVPAct in the House this week

Today in managed care: The AP reports that on Tuesday, the FDA “approved a generic medication for a rare brain disorder, while walking back statements by” the President “that the drug showed great promise for people with autism.” apnews.com/97a1b5092de76b…

Today in managed care: Bloomberg Law reports the FDA “is easing some requirements for drugmakers developing copycat versions of costly biologic medications in a bid to bring more competition to the market and lower costs.” news.bloomberglaw.com/health-law-and…